Aklank Jain

13PUBLICATIONS
26CO-AUTHORS
Medical devicesMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 13, 2026
Artificial Intelligence as an Assistive Tool in Breast Cancer Screening and Diagnosis in the Digital Era.

|Mar 28, 2025
MYOSLID: A Critical Modulator of Cancer Hallmarks.

Kanupriya Medhi, Sagarika Mukherjee, Aastha Dagar

|Mar 26, 2025
Clinical Significance of LINC00261 in the Pathogenesis of Pancreatic, Colorectal, Hepatocellular, and Gallbladder Cancer.

Sanjana Bana, Sia Daffara, Aastha Dagar

|Nov 22, 2024
LncRNAs SOX2-OT and NEAT1 act as a potential biomarker for esophageal squamous cell carcinoma.

Rajiv Ranjan Kumar, Adrija Mohanta, Manjit Kaur Rana

|Sep 29, 2024
The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer.

Ritu Yadav, Rinku Khatkar, Kenneth C-H Yap

|Sep 16, 2024
Immune-Related Long Non-Coding RNA Signature Determines Prognosis and Immunotherapeutic Coherence in Esophageal Cancer.

Vivek Uttam, Harmanpreet Singh Kapoor, Manjit Kaur Rana

Pageof 3

Frequent Collaborators

4 joint publications

Vivek Uttam

4 joint publications

Uttam Sharma

4 joint publications

Hardeep Singh Tuli

3 joint publications

Hridayesh Prakash